Uramoto Hidetaka, Yamada Sohsuke, Hanagiri Takeshi
Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
J Cardiothorac Surg. 2010 Oct 29;5:92. doi: 10.1186/1749-8090-5-92.
adenosquamous carcinoma (ADSQ) of non-small cell lung cancer (NSCLC) is a rare disease and the biological behavior and clinicopathological characteristics have not yet been thoroughly described.
This study reviewed the patient charts of 11 (1.6%) ADSQ cases among 779 patients with primary lung cancer who underwent a lung resection. The characteristics and clinicopathological factors were evaluated retrospectively.
Six of the 11 patients with ADSQ were male and five were female. The mean age was 67.3 years' olds. Three patients had pathological stage IA, one patient each had stage IB and IIA, five patients had stage IIIA, and one patient stage IIIB. Five patients had coexistent double cancer including 2 gastric, 1 rectal, 1 prostate and 1 bladder cancer. ADSQ was found less frequently in males than squamous cell carcinoma (SQ). ADSQ was found more frequently in older patients, with advanced stage, advanced T status, and lymph node metastases than adenocarcinoma (AD). The proportion with coexistent double cancer of AD, SQ, and ADSQ were 21.1, 17.6, and 45.5%, respectively. ADSQ had a significantly correlation with double cancer (ADSQ vs. non- ADSQ p = 0.03). A multivariate analysis showed no significant prognostic difference between the patients with ADSQ and non- ADSQ.
In this study, cases with ADSQ showed no significantly prognostic difference in comparison to AD and SQ. However, surgeons must be cautious of any coexistent double cancer because approximately half of all patients with ADSQ of the lung have double cancer.
非小细胞肺癌(NSCLC)中的腺鳞癌(ADSQ)是一种罕见疾病,其生物学行为和临床病理特征尚未得到充分描述。
本研究回顾了779例行肺切除术的原发性肺癌患者中的11例(1.6%)腺鳞癌病例的病历。对其特征和临床病理因素进行回顾性评估。
11例腺鳞癌患者中6例为男性,5例为女性。平均年龄为67.3岁。3例患者为病理IA期,1例患者分别为IB期和IIA期,5例患者为IIIA期,1例患者为IIIB期。5例患者并存双癌,包括2例胃癌、1例直肠癌、1例前列腺癌和1例膀胱癌。腺鳞癌在男性中的发病率低于鳞状细胞癌(SQ)。与腺癌(AD)相比,腺鳞癌在老年患者、晚期、高T分期和有淋巴结转移的患者中更常见。腺癌、鳞状细胞癌和腺鳞癌并存双癌的比例分别为21.1%、17.6%和45.5%。腺鳞癌与双癌有显著相关性(腺鳞癌与非腺鳞癌,p = 0.03)。多因素分析显示,腺鳞癌患者与非腺鳞癌患者之间无显著的预后差异。
在本研究中,腺鳞癌病例与腺癌和鳞状细胞癌相比,预后无显著差异。然而,外科医生必须警惕任何并存的双癌,因为大约一半的肺腺鳞癌患者患有双癌。